The Influence of Bevacizumab Combined with TP Regimen Chemotherapy on Serum Tumor Markers and Adverse Reactions inPatients with Advanced Cervical Cancer/， .// Medical Innovation of China，2025，22(19)： 010-014

    [Abstract]Objective： To explore the effcts of Bevacizumab and TP regimen (Paclitaxel plus Cisplatin) chemotherapy onserum tumor markers and adverse reactions in patients with advancedcervical cancer.Method： A total of 86 patients with advanced cervical cancer admited to Fengcheng People's Hospital from June2O21 to December 2023 were selected as the subjects.They were divided into two groups according to the random number table method， with 43 cases in each group.The control group was treated with the TP regimen， while the observation group was treated with Bevacizumabinaddition to thecontrol group.Theclinical eficacy，serum tumor markers，Tcellsubsets， tumor diameter，qualityof life and adverse reactions of thetwo groups were compared.Result： After treatment，the total effective rate of the observation group was higher than that of the control group ( P lt;0.05).After treatment ......